Deadline Soon: Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud LawsuitNovember 07, 2025 at 17:01 PM EST
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON LANTHEUS HOLDINGS, INC. (LNTH), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT. What Happened? On May 7, 2025, Lantheus released its first quarter 2025 financial results, missing consensus estimates, specifically with the Company’s key Radiopharmaceutical Oncology product, Pylarify. The Company disclosed that Pylarify sales had decreased year-over-year due to an alleged “temporal competitive disruption.” Additionally, the Company reduced its full-year guidance. On this news, Lantheus’s stock price fell $24.35, or 23.2%, to close at $80.49 per share on May 7, 2025, thereby injuring investors. Then, on August 6, 2025, Lantheus released its second quarter 2025 financial results, once again missing estimates and significantly reduced growth expectations for Pylarify, due to ongoing completion impacting pricing dynamics. The Company further slashed its full-year guidance. On this news, Lantheus’s stock price fell $20.76, or 28.6%, to close at $51.87 per share on August 6, 2025, thereby injuring investors further. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Lantheus did not have an accurate understanding of the pricing and competitive dynamics of Pylarify’s market; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Lantheus securities between February 26, 2025 and August 5, 2025, the deadline to seek appointment as the lead plaintiff in the securities fraud class action is November 10, 2025. Contact Us To Participate or Learn More:
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact us:
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. View source version on businesswire.com: https://www.businesswire.com/news/home/20251107161832/en/ ContactsContact Us:
The Law Offices of Frank R. Cruz, Los Angeles
More NewsView More
3 Stocks Poised to Benefit From Google’s AI Breakthough ↗
December 03, 2025
Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026 ↗
December 03, 2025
3 Stocks You’ll Wish You Bought Before 2026 ↗
December 03, 2025
Via MarketBeat
Wall Street Punished CrowdStrike for Beating Earnings? Seriously? ↗
December 03, 2025
Via MarketBeat
Tickers
CRWD
Okta: Excuses to Sell Vs. Reasons to Buy ↗
December 03, 2025
Via MarketBeat
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|